Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

European Life Sciences Sector Embraces Home-Working: 37% Work from Home at Least Once a Week

By Sciad Newswire | October 11, 2016

According to new research from specialist recruiter Hobson Prior, home-working is growing ever more popular in the life sciences sector: 32 percent of professionals surveyed have seen an increase in the number of home-working opportunities available. Almost three quarters of these individuals reported working from home at least occasionally, 37 percent do so at least one day per week, and 11 percent are fully home-based. 

Career trends in life sciences surveyed 1,527 individuals working in the European life sciences industry. Focusing on skills shortage and its impact on careers, the report suggests employers are increasingly acknowledging the usefulness of home-working as a way to reduce overheads, recruit remote workforces, and attract and retain top talent.

The benefits for employees are manifold. “Working from home can promote a healthier work-life balance, as well as creating a greater sense of trust and autonomy,” comments Jake Thomas, Managing Director of Hobson Prior. “Some people feel it makes them much more productive too.”

According to the report, flexible working is most common in the Netherlands, with 70 percent working from home at least occasionally. Yet Spain has the most professionals who are completely home-based (34 percent), and an impressive 48 percent of French respondents say they work from home at least one day per week. France has long been ahead of the curve in promoting work-life balance, and its consultancies are now banned from asking staff to check emails outside of 9am-6pm. The UK sits just above average, with 39 percent working from home at least one day per week.

Conversely, Ireland has the highest percentage of respondents who never or rarely work from home (63 percent), as well as the lowest percentage that have seen an increase in home-working opportunities (14 percent).

Those in clinical operations and clinical research and development are the most likely to work mostly from home. “Home-working can really suit CRAs and CPMs, as their work allows much of their interaction with colleagues to be done remotely,” explains James Inwood, Hobson Prior’s Clinical Team Leader. “It’s certainly becoming more common in CROs, which aim to cut costs by reducing office-based staff.”

Yet although a more cost-efficient and content workforce may sound appealing, the report warns employers to ensure the appropriate infrastructure is in place before encouraging employees to work from home. On the subject, one respondent commented: “Home-working requires a good attitude from colleagues, management skills from managers and technical support for the employee.”

Without these fundamentals, home working can quickly lead to employees feeling isolated and lacking control, with one respondent commenting: “In my last company I was completely home-based, but with no support or integration I decided I would rather leave and commute to another country instead.”

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news! 


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE